Study Reveals Distinct Outcomes in Younger Patients With Grade 3 Oligodendroglioma

May 19th 2025, 1:00pm

By Spencer Feldman

Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients, a study found.

Fatigue, Sleep and Urinary Symptoms Affect Cognition in Prostate Cancer

May 18th 2025, 6:00pm

By Spencer Feldman

Managing fatigue, sleep, urinary symptoms and depression is key to improving cognitive function in those receiving radiation therapy for prostate cancer.

Providing Care and Listening With Compassion During Cancer

May 18th 2025, 2:00pm

By Grace Allison, B.S.N., RN, OCN, RN-BC

Tagrisso Therapy Elicits Wave of New Therapeutic Approaches in NSCLC

May 17th 2025, 6:00pm

By Dr. Suresh S. Ramalingam

Dr. Suresh Ramalingam discussed how the LAURA findings support the role of Tagrisso as a backbone therapy across multiple settings in EGFR-mutated NSCLC.

Cancer Didn’t Break Me; It Revealed My Strength

May 17th 2025, 2:00pm

By Nicole Boyd

I’m a single mom with chronic lymphocytic leukemia sharing how cancer tested me but revealed my resilience, hardship and the power of speaking up.

EPA Deregulation Means More Air Pollution and More Cancer Deaths

May 16th 2025, 9:00pm

By Dr. Joan H. Schiller

Recently, the American Lung Association released the 2025 “State of the Air” report.

Understanding Unique Treatment Options Across Bladder Cancer Care

May 16th 2025, 8:00pm

By Dr. Daniel Petrylak

Dr. Daniel P. Petrylak discusses the different types of bladder cancer and how treatment options may vary based on disease stage and type.

Brain Cancer Awareness Month Highlights Advances in Radiation Therapy

May 16th 2025, 7:01pm

By Ryan Scott

Dr. Ranjit S. Bindra discusses recent advancements for the treatment of patients with primary brain tumors during Brain Cancer Awareness Month.

Tips for Combating Lymphedema After Breast Cancer

May 16th 2025, 5:00pm

By Felicia Mitchell

With proper precautions, international travel and safeguarding an arm with lymphedema are possible. Always prioritize your health and seek medical advice.

Samuraciclib Therapy Combo Shows Responses in HR+ Advanced Breast Cancer

May 16th 2025, 4:00pm

By Ryan Scott

Recent phase 2 data support combination treatment with samuraciclib for those with HR+ advanced breast cancer following prior CDK4/6 inhibitor therapy.

Leronlimab Linked to Increased PD-L1 in Triple-Negative Breast Cancer

May 16th 2025, 2:41pm

By Spencer Feldman

Leronlimab increased PD-L1 in patients with triple-negative breast cancer, potentially making cold tumors responsive to immune checkpoint inhibitors.

Preparing For Survivorship After Lymphoma Treatment in AYA Patients

May 16th 2025, 1:00pm

By Dr. Kara Kelly

Dr. Kara Kelly discusses specific long-term health considerations that AYA survivors of lymphoma should be aware of to best prepare for survivorship.

Bladder Cancer Awareness Month Highlights the Importance of Early Detection

May 15th 2025, 9:00pm

By Ryan Scott

Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the disease.

Robotic Kidney Cancer Surgery May Aid Recovery, Spare Kidney Function

May 15th 2025, 8:00pm

By Dr. Armine Smith

Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith.

FDA Approves Zynyz Treatment Regimen for Advanced Anal Cancer

May 15th 2025, 7:27pm

By Spencer Feldman

The FDA has approved Zynyz as a first-line treatment in combination with chemo and as a single-agent following progression in advanced anal cancer.